info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Deflazacort (Calcort)
503
Article source: Seagull Pharmacy
Oct 17, 2025

Deflazacort (Calcort) is a glucocorticoid drug mainly used to treat a variety of inflammatory and autoimmune diseases.

Indications for Deflazacort (Calcort)

Duchenne Muscular Dystrophy (DMD)

Deflazacort has been approved by the FDA for the treatment of Duchenne Muscular Dystrophy (DMD) in patients aged 5 years and older, which is the primary indication of this drug.

Clinical studies have shown that deflazacort can delay the degeneration of muscle function in DMD patients, improve motor function, and prolong the duration of maintaining walking ability.

Inflammatory and Autoimmune Diseases

Deflazacort can also be used to treat a variety of inflammatory and autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, severe asthma, and allergic diseases.

Its anti-inflammatory effect is approximately 70% that of prednisone, but it has relatively fewer side effects.

Specifications and Properties of Deflazacort (Calcort)

Oral Suspension

The specification of the newly approved deflazacort oral suspension is 22.75mg/mL.

This suspension is a combination product, consisting of the drug and device components.

Tablets

Common specifications of deflazacort tablets include 6mg, 18mg, and 30mg. The tablets are generally white or off-white, and their specific properties may vary slightly among different manufacturers.

The tablets should be swallowed whole and should not be split or crushed.

Storage and Usage of Deflazacort (Calcort)

Storage Conditions

Both deflazacort oral suspension and tablets should be stored at room temperature (20-25°C), with short-term storage allowed in an environment of 15-30°C.

It is important to keep the drug out of the reach of children and avoid direct sunlight and humid environments.

The suspension should remain in intact packaging before opening; after opening, it should be stored in accordance with the requirements in the instruction manual.

Oral Suspension

It should be shaken thoroughly before use.

A dedicated dosing device should be used to measure the dose accurately.

It can be mixed with a small amount of water or fruit juice for administration to improve taste.

After opening, it must be used up within the specified time.

Tablets

It is recommended to take the tablets after breakfast in the morning to conform to the body's cortisol secretion rhythm.

The tablets should be swallowed whole and should not be chewed or crushed.

Patients taking the drug for a long time should not discontinue it suddenly; the dose needs to be reduced gradually.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Use Deflazacort (Calcort)
Deflazacort (Calcort) is a glucocorticoid drug with anti-inflammatory and immunosuppressive effects. Clinically, it is mainly used to treat various inflammatory diseases and autoimmune diseases. The r...
Precautions for Administration of Deflazacort (Calcort)
Deflazacort (Calcort) is a glucocorticoid drug primarily used for the treatment of Duchenne muscular dystrophy (DMD) and other inflammatory or autoimmune diseases. As a hormonal drug that requires lon...
How Effective is Deflazacort (Calcort) in Treatment?
Deflazacort (Calcort) is a glucocorticoid drug, and its active ingredient, Deflazacort, exerts anti-inflammatory and immunosuppressive effects.How Effective is Deflazacort (Calcort) in Treatment?Main ...
What Are the Side Effects of Deflazacort (Calcort)?
Deflazacort (Calcort) is a glucocorticoid drug primarily used for the treatment of Duchenne muscular dystrophy (DMD) as well as other inflammatory or autoimmune diseases. Although its efficacy is well...
Precautions for Eltrombopag (Revolade) Use
Eltrombopag (Revolade) is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia (ITP), chronic hepatitis C-associated thrombocytopenia, and severe aplastic anemia. It increas...
How to Use Eltrombopag (Revolade)
Eltrombopag (Revolade) is a thrombopoietin receptor agonist, primarily used clinically for the treatment of chronic immune thrombocytopenia (ITP), chronic hepatitis C-associated thrombocytopenia, and ...
Indications for Eltrombopag (Revolade)
Eltrombopag (Revolade) is a thrombopoietin receptor agonist developed by GlaxoSmithKline, mainly used to treat thrombocytopenia caused by various reasons.Indications for Eltrombopag (Revolade)Chronic ...
What Are the Side Effects of Eltrombopag (Revolade)
Eltrombopag (Revolade) is a thrombopoietin receptor agonist used to treat specific types of thrombocytopenia and aplastic anemia. Although it has good efficacy, potential side effects and precautions ...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved